<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0"
  xmlns:content="http://purl.org/rss/1.0/modules/content/"
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:media="http://search.yahoo.com/mrss/"
  xmlns:atom="http://www.w3.org/2005/Atom"
  xmlns:georss="http://www.georss.org/georss">

  <channel>
    <title>
      <![CDATA[  the cedar ledge  ]]>
    </title>
    <link> https://jacobzelko.com </link>
    <description>
      <![CDATA[  Jacob S. Zelko&#39;s personal website  ]]>
    </description>
    <atom:link
      href="https://jacobzelko.com/feed.xml"
      rel="self"
      type="application/rss+xml" />


<item>
  <title>
    <![CDATA[  FDA Amendment Act  ]]>
  </title>
  <link> https://jacobzelko.com/07282021175202-fda-risk-prevention/index.html </link>
  <guid> https://jacobzelko.com/07282021175202-fda-risk-prevention/index.html </guid>
  <description>
    <![CDATA[  How the FDA addressed concerns about drug recalls  ]]>
  </description>  
  
  <content:encoded>
    <![CDATA[  
<h1>FDA Amendment Act</h1>
<p><strong>Date:</strong> July 28 2021</p>
<p><strong>Summary:</strong> How the FDA addressed concerns about drug recalls</p>
<p><strong>Keywords:</strong> #food #drug #administration #omop #act #congress #sentinel #initiative #archive</p>
<h1>Bibliography</h1>
<p>EHDEN Academy</p>
<h1>Table of Contents</h1>
<div class="franklin-toc"><ol><li>How To Cite</li><li>References:</li><li>Discussion: </li></ol></div>
<ul>
<li><p>FDA thought clinical trials for drug testing was:</p>
</li>
</ul>
<pre><code class="language-julia">- Too short
- Too small scale</code></pre>
<ul>
<li><p>FDA requested observational testing of released drugs based on actual patients</p>
</li>
<li><p>US Congress passed the FDA Amendment Act</p>
</li>
</ul>
<pre><code class="language-julia">- Establishing a Risk Identification and Analysis System
	- Framework to generate evidence to characterise any possible effects from drugs in use
	- Utilizes observational healthcare data sources
- Sentinel Initiative created by FDA
	- Surveys and studies effects of drugs on patients</code></pre>
<ul>
<li><p>Lack of regulation and drug approval guidelines after decision</p>
</li>
</ul>
<pre><code class="language-julia">- Required industry partnerships 
- Culminated in the creation of the &#91;Observational Medical Outcomes Partnership &#40;OMOP&#41;&#93;&#40;https://jacobzelko.com/07282021181744-origins-omop&#41;</code></pre>
<h2 id="how_to_cite">How To Cite</h2>
<p>Zelko, Jacob. <em>FDA Amendment Act</em>. <a href="https://jacobzelko.com/07282021175202-fda-risk-prevention">https://jacobzelko.com/07282021175202-fda-risk-prevention</a>. July 28 2021.</p>
<h2 id="references">References:</h2>
<h2 id="discussion">Discussion: </h2>
<script>talkyardServerUrl='https://site-vbm8wbc57o.talkyard.net';</script>
<script async defer src="https://c1.ty-cdn.net/-/talkyard-comments.min.js"></script>
<div class="talkyard-comments" data-discussion-id="" style="margin-top: 45px;">
    <noscript>Please enable Javascript to view comments.</noscript>
</div> ]]>
  </content:encoded>
    
  <pubDate>Wed, 28 Jul 2021 00:00:00 +0000</pubDate>  
  
  
  <atom:author>
    <atom:name>Jacob Zelko</atom:name>
  </atom:author>
        
</item>
</channel></rss>